Varenicline (Chantix)

DRUG4 trials

Sponsors

Massachusetts General Hospital, Yale University, Duke University, Medical University of South Carolina

Conditions

Attention Deficit/Hyperactivity DisorderCannabis AbuseCigarette SmokingNicotine DependenceSmoking Cessation

Early Phase 1

Smoking Cessation Treatment for Head and Neck Cancer Patients

TerminatedNCT00931021

Yale UniversitySmoking Cessation

Start: 2009-07-31End: 2012-12-31Updated: 2013-07-15

Phase 2

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

TerminatedNCT01560507

Duke UniversityCigarette Smoking, Nicotine Dependence

Start: 2012-05-31End: 2013-07-31Updated: 2014-12-24

Varenicline as a Treatment for Cannabis Use Disorder

Not yet recruitingNCT07783555

Medical University of South CarolinaCannabis Abuse

Start: 2026-12-01End: 2031-11-30Target: 224Updated: 2026-08-25

Phase 4

Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)

TerminatedNCT00907218

Massachusetts General HospitalAttention Deficit/Hyperactivity Disorder, Smoking Cessation

Start: 2009-04-30End: 2010-05-31Updated: 2017-10-20